Visualization of the Effect of Acupuncture on Brain Serotonin in Breast Cancer Survivors
Status: | Completed |
---|---|
Conditions: | Breast Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | March 2009 |
End Date: | December 2010 |
Effect of Acupuncture on Brain Serotonin Among Breast Cancer Survivors
RATIONALE: New imaging procedures, such as single photon emission computed tomography, may
help in learning how acupuncture affects serotonin levels in the brain of breast cancer
survivors. PURPOSE: This phase I trial is studying the best way to visualize the effect of
acupuncture on brain serotonin in breast cancer survivors.
help in learning how acupuncture affects serotonin levels in the brain of breast cancer
survivors. PURPOSE: This phase I trial is studying the best way to visualize the effect of
acupuncture on brain serotonin in breast cancer survivors.
Detailed Description
OBJECTIVES:
I. To determine the feasibility of using [123-I] ADAM Serotonin transporter (SERT) binding
as a putative biomarker to visualize the mechanism of effects of acupuncture for hot flashes
involving serotonin.
OUTLINE: Patients undergo acupuncture twice weekly for 2 weeks and then once weekly for 6
weeks. Patients undergo single photon emission computed tomography imaging with iodine 123-I
ADAM before and after completion of acupuncture.
After completion of study treatment, patients are followed for 4 weeks.
OBJECTIVES:
I. To determine the feasibility of using [123-I] ADAM Serotonin transporter (SERT) binding
as a putative biomarker to visualize the mechanism of effects of acupuncture for hot flashes
involving serotonin.
OUTLINE: Patients undergo acupuncture twice weekly for 2 weeks and then once weekly for 6
weeks. Patients undergo single photon emission computed tomography imaging with iodine 123-I
ADAM before and after completion of acupuncture.
After completion of study treatment, patients are followed for 4 weeks.
Inclusion Criteria:
- History of Stage I, II, or III breast cancer for at least 12 months
- Have been seen by an oncologist within the previous 6-month period and determined to
be free of disease by clinical examination and history
- Have been receiving endocrine therapy (tamoxifen or aromatase inhibitors for at least
four weeks)
- Experienced hot flashes with a hot flash composite score of 5 or greater per day
- Hot flashes have been present for at least a month before study entry
Exclusion Criteria:
- Currently on chemotherapy or radiation therapy as adjuvant treatment
- Started with hormonal therapies such as tamoxifen or aromatase inhibitors within the
last 4 weeks; or plan to change or terminate hormonal therapies in the next 14 weeks
- Any history of use of psychotropic medication such as SSRI use for the past 6 months
- Any past use of centrally acting medications such as clonidine for the past 6 months
- Any past diagnosis of a Major Depressive Episode within the last 6 months
- Any allergy to iodine or shell-fish or radio-nuclear materials
- Current use of estrogen and/or progestin
- Pregnancy
- Breast feeding
- Women of child-bearing potential NOT willing to use a medically acceptable form of
contraception
- Current use of any anti-convulsant such as gabapentin
- History of cerebral infarction (including lacunar infarct with symptoms >= 24 hours
duration)
- History of Binswanger's disease (or a history of hypertensive encephalopathy)
- History of intracranial hemorrhage
- History of head trauma with loss of consciousness
- History of encephalitis
- History of extended exposure to known neurotoxin (e.g., cyanide, carbon monoxide)
- Uncontrolled metabolic disorder (e.g., thyroid disease, diabetes mellitus)
- History of normal pressure hydrocephalus
- History of Parkinson's or other basal ganglia disease
- History of substance abuse in the previous 6 months
We found this trial at
1
site
3400 Civic Center Blvd
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
(215) 662-6065
Abramson Cancer Center of the University of Pennsylvania The Abramson Cancer Center of the University...
Click here to add this to my saved trials